Furthermore, a substantial reduction in LRP1 in endothelial cells and pericytes levels was found in our study, by approximately 56% and 49%, respectively, consistent with a reduction in AD patients (Halliday et al., 2016). This evidence concerns the gene LRP1 and Alzheimer disease.